United States
Germany
Japan
United Kingdom
China
CITED1 (Myc-DDK-tagged)-Human Cbp/p300-interacting transactivator, with Glu/Asp-rich carboxy-terminal domain, 1 (CITED1), transcript variant 1
| Type | Human Tagged ORF Clone |
| Tag | Myc-DDK |
| Vector | pCMV6-Entry |
Products
CITED1 (Myc-DDK-tagged)-Human Cbp/p300-interacting transactivator, with Glu/Asp-rich carboxy-terminal domain, 1 (CITED1), transcript variant 3
| Type | Human Tagged ORF Clone |
| Tag | Myc-DDK |
| Vector | pCMV6-Entry |
CITED1 (Myc-DDK-tagged)-Human Cbp/p300-interacting transactivator, with Glu/Asp-rich carboxy-terminal domain, 1 (CITED1), transcript variant 4
| Type | Human Tagged ORF Clone |
| Tag | Myc-DDK |
| Vector | pCMV6-Entry |
CITED1 mouse monoclonal antibody, clone OTI3C12 (formerly 3C12)
| Applications | IHC, WB |
| Reactivities | Human |
CITED1 mouse monoclonal antibody, clone OTI3B1 (formerly 3B1)
| Applications | WB |
| Reactivities | Human |
CITED1 mouse monoclonal antibody, clone OTI4H4 (formerly 4H4)
| Applications | WB |
| Reactivities | Human |
CITED1 mouse monoclonal antibody, clone OTI3B8 (formerly 3B8)
| Applications | WB |
| Reactivities | Human |
CITED1 mouse monoclonal antibody, clone OTI2H7 (formerly 2H7)
| Applications | WB |
| Reactivities | Human |
CITED1 mouse monoclonal antibody, clone OTI1E11 (formerly 1E11)
| Applications | WB |
| Reactivities | Human |
CITED1 mouse monoclonal antibody, clone OTI3C12 (formerly 3C12)
| Applications | IHC, WB |
| Reactivities | Human |
CITED1 mouse monoclonal antibody, clone OTI1C6 (formerly 1C6)
| Applications | WB |
| Reactivities | Human |
CITED1 mouse monoclonal antibody, clone OTI4H4 (formerly 4H4)
| Applications | WB |
| Reactivities | Human |
CITED1 mouse monoclonal antibody, clone OTI3B1 (formerly 3B1)
| Applications | WB |
| Reactivities | Human |
CITED1 mouse monoclonal antibody, clone OTI2H7 (formerly 2H7)
| Applications | WB |
| Reactivities | Human |
CITED1 mouse monoclonal antibody, clone OTI3B8 (formerly 3B8)
| Applications | WB |
| Reactivities | Human |
